- Home
- CCM vs NRSN Comparison
CCM vs NRSN Comparison
Compare CCM & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- NRSN
- Stock Information
- Founded
- CCM 1997
- NRSN 2017
- Country
- CCM China
- NRSN Israel
- Employees
- CCM N/A
- NRSN N/A
- Industry
- CCM Medical/Nursing Services
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- NRSN Health Care
- Exchange
- CCM Nasdaq
- NRSN Nasdaq
- Market Cap
- CCM 25.6M
- NRSN 29.8M
- IPO Year
- CCM 2009
- NRSN 2021
- Fundamental
- Price
- CCM $5.70
- NRSN $1.19
- Analyst Decision
- CCM
- NRSN Buy
- Analyst Count
- CCM 0
- NRSN 2
- Target Price
- CCM N/A
- NRSN $14.00
- AVG Volume (30 Days)
- CCM 26.0K
- NRSN 218.9K
- Earning Date
- CCM 09-26-2025
- NRSN 09-17-2025
- Dividend Yield
- CCM N/A
- NRSN N/A
- EPS Growth
- CCM N/A
- NRSN N/A
- EPS
- CCM N/A
- NRSN N/A
- Revenue
- CCM $51,056,841.00
- NRSN N/A
- Revenue This Year
- CCM N/A
- NRSN N/A
- Revenue Next Year
- CCM N/A
- NRSN N/A
- P/E Ratio
- CCM N/A
- NRSN N/A
- Revenue Growth
- CCM N/A
- NRSN N/A
- 52 Week Low
- CCM $3.80
- NRSN $0.80
- 52 Week High
- CCM $10.77
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- CCM 47.73
- NRSN 45.34
- Support Level
- CCM $5.62
- NRSN $1.17
- Resistance Level
- CCM $6.96
- NRSN $1.27
- Average True Range (ATR)
- CCM 0.49
- NRSN 0.07
- MACD
- CCM 0.00
- NRSN 0.00
- Stochastic Oscillator
- CCM 22.25
- NRSN 39.04
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.